Novo Dips After CagriSema’s Latest Lower-Than-Expected Weight Loss Readout BioSpace
Month: March 2025
Michael Mosley’s son writes book on weight-loss drugs continuing father’s work – The Independent
Michael Mosley’s son writes book on weight-loss drugs continuing father’s work The Independent
Novo Nordisk’s CagriSema shows nearly 16 percent weight loss – PharmaLive
Novo Nordisk’s CagriSema shows nearly 16 percent weight loss PharmaLive
Novo Nordisk (NVO) Shares Drop After Weight Loss Drug Trial Resu – GuruFocus.com
Novo Nordisk (NVO) Shares Drop After Weight Loss Drug Trial Resu GuruFocus.com
Karan Johar On Ozempic For Weight Loss: “Being Healthy, Eating Well And Exercising” – NDTV
Karan Johar On Ozempic For Weight Loss: “Being Healthy, Eating Well And Exercising” NDTV
Novo Nordisk (NVO) Shares Drop After Weight Loss Drug Trial Resu – GuruFocus.com
Novo Nordisk (NVO) Shares Drop After Weight Loss Drug Trial Resu GuruFocus.com
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with – GlobeNewswire
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with GlobeNewswire
Ozempic parent’s new weight-loss drug works better, but not quite good enough – MarketWatch
Ozempic parent’s new weight-loss drug works better, but not quite good enough MarketWatch
This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy? – The Motley Fool
This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy? The Motley Fool
Novo Nordisk trial with next-gen diabetes drug shows 15.7% weight loss but shares fall – TradingView
Novo Nordisk trial with next-gen diabetes drug shows 15.7% weight loss but shares fall TradingView